A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis

1. Fleischmann, R.M.
2. Bliddal, H.
3. Blanco, F.J.
4. Schnitzer, T.J.
5. Peterfy, C.
6. Chen, S.
7. Wang, L.
8. Feng, S.
9. Conaghan, P.G.
10. Berenbaum, F.
11. Pelletier, J.-P.
12. Martel-Pelletier, J.
13. Vaeterlein, O.
14. Kaeley, G.S.
15. Liu, W.
16. Kosloski, M.P.
17. Levy, G.
18. Zhang, L.
19. Medema, J.K.
20. Levesque, M.C.